Stay updated on Cabozantinib for NSCLC Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.

Latest updates to the Cabozantinib for NSCLC Brain Metastases Clinical Trial page
- Check3 days agoChange Detected- The page revision in the footer updated from v3.6.4 to v3.6.5. This reflects a new build/version of the page without changing substantive content.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe page revision label now shows v3.6.4, indicating a new site version has been deployed.SummaryDifference0.1%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3. This indicates a newer page revision rather than a change to study details.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page revision number was updated from v3.6.0 to v3.6.2, indicating a minor maintenance or template update. There are no changes to study details, eligibility criteria, or results content.SummaryDifference0.1%

- Check61 days agoChange DetectedThe page now states that recruitment is no longer ongoing, clarifying the trial's enrollment status. It also adds new help/navigation items (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with a revision tag to v3.6.0.SummaryDifference0.5%

- Check68 days agoChange DetectedThe page now shows a new Revision: v3.5.5, replacing v3.5.4, indicating a small site update without changes to the study details.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for NSCLC Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for NSCLC Brain Metastases Clinical Trial page.